Lauxera Capital Partners invests in GenePlanet in private funding round

PUBT · 2d ago
Lauxera Capital Partners invests in GenePlanet in private funding round
  • Lauxera Capital Partners invested in GenePlanet in a private financing to fund global expansion in advanced diagnostics and genetic testing.
  • GenePlanet is a European genomics and laboratory platform providing genetic testing and next-generation sequencing services worldwide.
  • Funding targets Western Europe and the U.S., including regulatory and reimbursement work, with product expansion into oncology and rare-disease panels.
  • BlackPeak Capital partially exited its 2023 investment, retaining a meaningful stake as GenePlanet targets a liquidity event in three to five years.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lauxera Capital Partners SAS published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein.